|
|
Sarcopenia and gastrointestinal cancer |
YU Jing, ZHOU Fu-xiang |
Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors and Hubei Cancer Clinical Study Center, Wuhan 430071, Hubei, China |
|
|
Abstract Sarcopenia is a clinic syndrome mainly characterized by skeleton muscle mass and function loss, which is common in the elderly, malnutrition, chronic inflammation and cancer. Malnutrition and sarcopenia are common in cancer patients, especially in gastrointestinal tumors. This paper was to investigate the incidence of sarcopenia and the influences of sarcopenia on treatment-related side effects and prognosis, further to clarify its clinical significances in gastrointestinal cancer patients. Key words such as “sarcopenia” and “cancer” were reviewed in “CNKI” and “Pubmed” databases. The results suggested that, firstly, sarcopenia was prevalent in gastrointestinal cancer, however, diagnostic criteria for sarcopenia were variable, and the standard diagnostic criterion for sarcopenia should include muscle mass assessment and functional status assessment. Secondly, sarcopenia had negative impact on tolerance to treatment and prognosis, including higher risk of severe chemotherapeutic toxicity, more surgical complications, longer length of stay in hospital and shorter survival. In conclusion, the assessment of sarcopenia is essential in gastrointestinal cancer patients, and may become an important means to predict the clinical outcomes of gastrointestinal cancer. Otherwise, it also suggest that clinical intervention on sarcopenia is of great significance.
|
|
|
|
|
[1] |
YUAN Xiao-xing. Relationship between uric acid and clinical features and prognosis of patients with advanced colon cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 316-319. |
[2] |
LU Chen, LIU Ling-xiang. The roles of energy balance factors on the prognosis of cancer survivors[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 261-265. |
[3] |
WANG Li-wei, WANG Jian-wei, JIA Wei, QIANG Wei, XUE Mei, MA Chao, WEI Xiu-qin. Correlation between platelet/lymphocyte ratio and clinical prognosis of small cell lung cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 196-199. |
[4] |
GE Shao-hua, CHEN Xing-yun, ZHANG Hai-yang, NING Tao, LI Hong-li, BA Yi. Study on the relationship between Glasgow prognostic score and nutritional, physical status in patients with gastric cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 212-215. |
[5] |
YI Hai-wei, LI Wen-li, YU Yun-lan, MA Dong-bo. The relative factors analysis of malnutrition status and sarcopenia in elderly patients[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 225-229. |
[6] |
LI Wei, GUO Zi-xing, LI Yong-hong, LIU Xiao-ping, HUANG Jing-yu, HU Wei-dong, LI Sheng. Analysis of expression and its clinical significance of UBE2T in lung cancer based on GEO database[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 242-245. |
|
|
|
|